PCV69 COST-EFFECTIVENESS OF ADD-ON THERAPY WITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) IN STATIN-TREATED PATIENTS WITH DYSLIPIDEMIA AND PERSISTENTLY LOW HDL-C IN THE UK AND GERMANY
Nov 1, 2005, 00:00
10.1016/S1098-3015(10)67480-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)67480-3/fulltext
Title :
PCV69 COST-EFFECTIVENESS OF ADD-ON THERAPY WITH PROLONGED-RELEASE NICOTINIC ACID (NIASPAN®) IN STATIN-TREATED PATIENTS WITH DYSLIPIDEMIA AND PERSISTENTLY LOW HDL-C IN THE UK AND GERMANY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67480-3&doi=10.1016/S1098-3015(10)67480-3
First page :
Section Title :
Open access? :
No
Section Order :
45